GlassScriptPhysician profile
Ginger Riddle
NPI 1164704086
$5,375.42
in general payments reported to CMS, 2019-2025
31 companies · $934 in 2025
The $934 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $484 · 2022: $839 · 2023: $1,971 · 2024: $1,148 · 2025: $934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,556 · Travel and Lodging: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,555.91 |
| Travel and Lodging | $496.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $777.91 | 2022-2025 | Carto 3, Nuvision Ice Catheter, Octaray Mapping Catheter |
| Boston Scientific Corporation | $544.53 | 2022-2023 | Varithena Administration Pack, Watchman Access System |
| Merck Sharp & Dohme LLC | $487.62 | 2021-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $487.16 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $484.63 | 2022-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $394.00 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $277.99 | 2022-2025 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $263.23 | 2021-2025 | Lifevest |
| Cvrx, INC. | $216.19 | 2022-2025 | Barostim Neo System |
| Abbott Laboratories | $141.85 | 2021-2024 | Ensite Precision, Cardiomems, Amplatzer Amulet |
| Novo Nordisk INC | $140.55 | 2023-2025 | Wegovy, Ozempic |
| Atricure, INC. | $140.15 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Epi-Ease Epicardial Access System, Atriclip Laa Exclusion System |
| Sanofi-Aventis U.S. LLC | $127.70 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $120.70 | 2023-2024 | Xarelto |
| Medtronic, INC. | $111.14 | 2022-2024 | Micra, Attain Command + Surevalve |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $107.33 | 2023 | Optimizer |
| Pfizer INC. | $91.11 | 2021-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $79.37 | 2022-2023 | Arcalyst |
| Cook Medical LLC | $67.88 | 2025 | Rosen |
| Lexicon Pharmaceuticals, INC. | $40.65 | 2023-2024 | Inpefa |
| Abiomed | $38.44 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $31.39 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $31.16 | 2021-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Biotronik INC. | $30.79 | 2021-2022 | |
| Philips North America LLC | $30.72 | 2024 | (Ck4) Mcot |
| Bayer Healthcare Pharmaceuticals INC. | $27.37 | 2025 | |
| Convatec INC. | $20.03 | 2024 | |
| Lundbeck LLC | $17.39 | 2021 | |
| Esperion Therapeutics, INC. | $16.38 | 2025 | Nexletol |
| Irhythm Technologies, INC. | $16.06 | 2024 | Zio Monitor, Zio Xt Patch |
| Bardy Diagnostics, INC. | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginger Riddle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.